Brief: Biogen Receives European Commission Approval For Zurzuvae
17/09/2025 22:20
Sept 17 (Reuters) - Biogen Inc BIIB.O: BIOGEN RECEIVES EUROPEAN COMMISSION APPROVAL FOR ZURZUVAE® (ZURANOLONE), THE FIRST AND ONLY TREATMENT APPROVED FOR WOMEN WITH POSTPARTUM DEPRESSION IN EUROPE Source text: ID:nGNXc4cjKj Further company coverage: BIIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Supernus Pharmaceuticals
See all newsHuron Consulting poised to hit fresh record ahead of S&P SmallCap addition
Brief: S&P Dow Jones Indices Msg Rangers And Huron Consulting Group Set To Join S&P Smallcap 600
Brief: Supernus Pharmaceuticals Says FDA Grants Seven Years Orphan-Drug Exclusivity For Onapgo
Supernus Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE -Micron Technology, Ares Management, Boeing